PD 0332991 and Cetuximab in Patients With Incurable SCCHN

Clinical trial NCT02101034 · COMPLETED

Trial details

NCT number: NCT02101034
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell of Head and Neck

Start date: 2014-06-17
Primary completion: 2020-06-08
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.